Comparative Effectiveness of Structural versus Regulatory Protein Gene Transfer on Articular Chondrocyte Matrix Gene Expression

Shuiliang Shi, Congrong Wang, Albert Chan, Kashif Kirmani, George J. Eckert, Stephen Trippel

Research output: Contribution to journalArticle

Abstract

Objective: The production of extracellular matrix is a necessary component of articular cartilage repair. Gene transfer is a promising method to improve matrix biosynthesis by articular chondrocytes. Gene transfer may employ transgenes encoding regulatory factors that stimulate the production of matrix proteins, or may employ transgenes that encode the proteins themselves. The objective of this study was to determine which of these 2 approaches would be the better choice for further development. We compared these 2 approaches using the transgenes encoding the structural matrix proteins, aggrecan or type II collagen, and the transgene encoding the anabolic factor, insulin-like growth factor I (IGF-I). Methods: We transfected adult bovine articular chondrocytes with constructs encoding type II collagen, aggrecan, or IGF-I, and measured the expression of type II collagen (COL2A1) and aggrecan (ACAN) from their native genes and from their transgenes. Results: IGF-I gene (IGF1) transfer increased the expression of the native chondrocyte COL2A1 and ACAN genes 2.4 and 2.9 times control, respectively. COL2A1 gene transfer did not significantly increase COL2A1 transcripts, even when the transgene included the genomic COL2A1 regulatory sequences stimulated by chondrogenic growth factors. In contrast, ACAN gene transfer increased ACAN transcripts up to 3.4 times control levels. IGF1, but not ACAN, gene transfer increased aggrecan protein production. Conclusion: Taken together, these results suggest that the type II collagen and aggrecan production required for articular cartilage repair will be more effectively achieved by genes that encode anabolic regulatory factors than by genes that encode the matrix molecules themselves.

Original languageEnglish (US)
Pages (from-to)102-110
Number of pages9
JournalCartilage
Volume10
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Gene transfer
Aggrecans
Regulator Genes
Chondrocytes
Gene expression
Joints
Proteins
Transgenes
Gene Expression
Collagen
Insulin
Collagen Type II
Genes
Cartilage
Insulin-Like Growth Factor I
Repair
Articular Cartilage
Biosynthesis
Level control
Molecules

Keywords

  • aggrecan
  • chondrocytes
  • gene transfer
  • growth factors
  • type II collagen

ASJC Scopus subject areas

  • Immunology and Allergy
  • Biomedical Engineering
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Comparative Effectiveness of Structural versus Regulatory Protein Gene Transfer on Articular Chondrocyte Matrix Gene Expression. / Shi, Shuiliang; Wang, Congrong; Chan, Albert; Kirmani, Kashif; Eckert, George J.; Trippel, Stephen.

In: Cartilage, Vol. 10, No. 1, 01.01.2019, p. 102-110.

Research output: Contribution to journalArticle

Shi, Shuiliang ; Wang, Congrong ; Chan, Albert ; Kirmani, Kashif ; Eckert, George J. ; Trippel, Stephen. / Comparative Effectiveness of Structural versus Regulatory Protein Gene Transfer on Articular Chondrocyte Matrix Gene Expression. In: Cartilage. 2019 ; Vol. 10, No. 1. pp. 102-110.
@article{6f1eb86282ba475e81062c7e93f1c502,
title = "Comparative Effectiveness of Structural versus Regulatory Protein Gene Transfer on Articular Chondrocyte Matrix Gene Expression",
abstract = "Objective: The production of extracellular matrix is a necessary component of articular cartilage repair. Gene transfer is a promising method to improve matrix biosynthesis by articular chondrocytes. Gene transfer may employ transgenes encoding regulatory factors that stimulate the production of matrix proteins, or may employ transgenes that encode the proteins themselves. The objective of this study was to determine which of these 2 approaches would be the better choice for further development. We compared these 2 approaches using the transgenes encoding the structural matrix proteins, aggrecan or type II collagen, and the transgene encoding the anabolic factor, insulin-like growth factor I (IGF-I). Methods: We transfected adult bovine articular chondrocytes with constructs encoding type II collagen, aggrecan, or IGF-I, and measured the expression of type II collagen (COL2A1) and aggrecan (ACAN) from their native genes and from their transgenes. Results: IGF-I gene (IGF1) transfer increased the expression of the native chondrocyte COL2A1 and ACAN genes 2.4 and 2.9 times control, respectively. COL2A1 gene transfer did not significantly increase COL2A1 transcripts, even when the transgene included the genomic COL2A1 regulatory sequences stimulated by chondrogenic growth factors. In contrast, ACAN gene transfer increased ACAN transcripts up to 3.4 times control levels. IGF1, but not ACAN, gene transfer increased aggrecan protein production. Conclusion: Taken together, these results suggest that the type II collagen and aggrecan production required for articular cartilage repair will be more effectively achieved by genes that encode anabolic regulatory factors than by genes that encode the matrix molecules themselves.",
keywords = "aggrecan, chondrocytes, gene transfer, growth factors, type II collagen",
author = "Shuiliang Shi and Congrong Wang and Albert Chan and Kashif Kirmani and Eckert, {George J.} and Stephen Trippel",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/1947603517719317",
language = "English (US)",
volume = "10",
pages = "102--110",
journal = "Cartilage",
issn = "1947-6035",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Comparative Effectiveness of Structural versus Regulatory Protein Gene Transfer on Articular Chondrocyte Matrix Gene Expression

AU - Shi, Shuiliang

AU - Wang, Congrong

AU - Chan, Albert

AU - Kirmani, Kashif

AU - Eckert, George J.

AU - Trippel, Stephen

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: The production of extracellular matrix is a necessary component of articular cartilage repair. Gene transfer is a promising method to improve matrix biosynthesis by articular chondrocytes. Gene transfer may employ transgenes encoding regulatory factors that stimulate the production of matrix proteins, or may employ transgenes that encode the proteins themselves. The objective of this study was to determine which of these 2 approaches would be the better choice for further development. We compared these 2 approaches using the transgenes encoding the structural matrix proteins, aggrecan or type II collagen, and the transgene encoding the anabolic factor, insulin-like growth factor I (IGF-I). Methods: We transfected adult bovine articular chondrocytes with constructs encoding type II collagen, aggrecan, or IGF-I, and measured the expression of type II collagen (COL2A1) and aggrecan (ACAN) from their native genes and from their transgenes. Results: IGF-I gene (IGF1) transfer increased the expression of the native chondrocyte COL2A1 and ACAN genes 2.4 and 2.9 times control, respectively. COL2A1 gene transfer did not significantly increase COL2A1 transcripts, even when the transgene included the genomic COL2A1 regulatory sequences stimulated by chondrogenic growth factors. In contrast, ACAN gene transfer increased ACAN transcripts up to 3.4 times control levels. IGF1, but not ACAN, gene transfer increased aggrecan protein production. Conclusion: Taken together, these results suggest that the type II collagen and aggrecan production required for articular cartilage repair will be more effectively achieved by genes that encode anabolic regulatory factors than by genes that encode the matrix molecules themselves.

AB - Objective: The production of extracellular matrix is a necessary component of articular cartilage repair. Gene transfer is a promising method to improve matrix biosynthesis by articular chondrocytes. Gene transfer may employ transgenes encoding regulatory factors that stimulate the production of matrix proteins, or may employ transgenes that encode the proteins themselves. The objective of this study was to determine which of these 2 approaches would be the better choice for further development. We compared these 2 approaches using the transgenes encoding the structural matrix proteins, aggrecan or type II collagen, and the transgene encoding the anabolic factor, insulin-like growth factor I (IGF-I). Methods: We transfected adult bovine articular chondrocytes with constructs encoding type II collagen, aggrecan, or IGF-I, and measured the expression of type II collagen (COL2A1) and aggrecan (ACAN) from their native genes and from their transgenes. Results: IGF-I gene (IGF1) transfer increased the expression of the native chondrocyte COL2A1 and ACAN genes 2.4 and 2.9 times control, respectively. COL2A1 gene transfer did not significantly increase COL2A1 transcripts, even when the transgene included the genomic COL2A1 regulatory sequences stimulated by chondrogenic growth factors. In contrast, ACAN gene transfer increased ACAN transcripts up to 3.4 times control levels. IGF1, but not ACAN, gene transfer increased aggrecan protein production. Conclusion: Taken together, these results suggest that the type II collagen and aggrecan production required for articular cartilage repair will be more effectively achieved by genes that encode anabolic regulatory factors than by genes that encode the matrix molecules themselves.

KW - aggrecan

KW - chondrocytes

KW - gene transfer

KW - growth factors

KW - type II collagen

UR - http://www.scopus.com/inward/record.url?scp=85061755943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061755943&partnerID=8YFLogxK

U2 - 10.1177/1947603517719317

DO - 10.1177/1947603517719317

M3 - Article

C2 - 28703018

AN - SCOPUS:85061755943

VL - 10

SP - 102

EP - 110

JO - Cartilage

JF - Cartilage

SN - 1947-6035

IS - 1

ER -